Jonathan Allan
General Counsel at Stoke Therapeutics, Inc. (STOK)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.6M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 2SEC | STOKStoke Therapeutics, Inc. | Sell Plan | 62720,598 held (−3%) | $26.33 | $17K | -6.0% |
| Aug 18SEC | STOKStoke Therapeutics, Inc. | Sell | 2,71621,370 held (−11%) | $32.01 | $87K | -22.7% |
| Aug 18SEC | STOKStoke Therapeutics, Inc. | Sell | 14521,225 held (−1%) | $32.47 | $5K | -23.8% |
| Jun 18SEC | STOKStoke Therapeutics, Inc. | Sell Plan | 1,45718,086 held (−7%) | $29.95 | $44K | -17.4% |
| Mar 24SEC | STOKStoke Therapeutics, Inc. | Sell Plan | 8,69220,144 held (−30%) | $33.64 | $292K | -26.5% |
| Mar 24SEC | STOKStoke Therapeutics, Inc. | Sell Plan | 60119,543 held (−3%) | $34.41 | $21K | -28.1% |
| Mar 19SEC | STOKStoke Therapeutics, Inc. | Sell | 2,47635,255 held (−7%) | $32.74 | $81K | -24.4% |
| Mar 19SEC | STOKStoke Therapeutics, Inc. | Sell | 1,79133,464 held (−5%) | $33.38 | $60K | -25.9% |
| Mar 19SEC | STOKStoke Therapeutics, Inc. | Sell | 4,22229,242 held (−13%) | $31.28 | $132K | -20.9% |
| Mar 19SEC | STOKStoke Therapeutics, Inc. | Sell | 33428,908 held (−1%) | $31.79 | $11K | -22.2% |
| Mar 19SEC | STOKStoke Therapeutics, Inc. | Sell | 7228,836 held (−0%) | $32.85 | $2K | -24.7% |
| Dec 10SEC | STOKStoke Therapeutics, Inc. | Sell Plan | 1,30014,509 held (−8%) | $31.60 | $41K | -21.7% |
| Dec 10SEC | STOKStoke Therapeutics, Inc. | Sell Plan | 2,67811,831 held (−18%) | $32.61 | $87K | -24.1% |
| Dec 5SEC | STOKStoke Therapeutics, Inc. | Sell Plan | 82424,788 held (−3%) | $30.76 | $25K | -19.6% |
| Dec 5SEC | STOKStoke Therapeutics, Inc. | Sell Plan | 19424,594 held (−1%) | $31.32 | $6K | -21.0% |
| Dec 5SEC | STOKStoke Therapeutics, Inc. | Sell Plan | 1,00423,590 held (−4%) | $31.33 | $31K | -21.0% |
| Dec 5SEC | STOKStoke Therapeutics, Inc. | Sell Plan | 5,43718,153 held (−23%) | $31.08 | $169K | -20.4% |
| Dec 5SEC | STOKStoke Therapeutics, Inc. | Sell Plan | 2,34415,809 held (−13%) | $31.76 | $74K | -22.1% |
| Dec 3SEC | STOKStoke Therapeutics, Inc. | Sell | 1,41622,772 held (−6%) | $29.56 | $42K | -16.3% |
| Dec 3SEC | STOKStoke Therapeutics, Inc. | Sell | 86821,904 held (−4%) | $30.14 | $26K | -17.9% |
| Dec 3SEC | STOKStoke Therapeutics, Inc. | Sell | 89821,006 held (−4%) | $30.34 | $27K | -18.5% |
| Dec 3SEC | STOKStoke Therapeutics, Inc. | Sell | 1,39419,612 held (−7%) | $30.85 | $43K | -19.8% |
| Oct 7SEC | STOKStoke Therapeutics, Inc. | Sell Plan | 10,00011,831 held (−46%) | $25.07 | $251K | -1.3% |
- Sell
General Counsel Jonathan Allan sold $17K of STOK at $26.33 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Jonathan Allan sold $44K of STOK at $29.95 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Jonathan Allan sold $292K of STOK at $33.64 — cuts the stake by 30%; pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Jonathan Allan sold $21K of STOK at $34.41 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Jonathan Allan sold $41K of STOK at $31.60 — pre-scheduled 10b5-1 plan sale.
- Sell
General Counsel Jonathan Allan sold $87K of STOK at $32.61 — pre-scheduled 10b5-1 plan sale.